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hen we experience a stressful event, the initial
response of the brain,body,and behavior is a protective
one,and hormones,cytokines,and other mediators,such
as the neurotransmitters,are used to survive and adapt
to the challenge.However,repeated stressful experiences
have deleterious effects,in part because the very same
mechanisms that help protect in the short term are now
either mismanaged and/or overused.
1And,over weeks,
months,and years,the dysregulation and overactivity of
these systems can promote changes that appear to be
deleterious,and stressful experiences have been reported
to be a major risk factor in the occurrence of depressive
disorders.For example,in the brain,the overactivity of
stress hormones in the blood and endogenous excitatory
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The brain interprets experiences and translates them into behavioral and physiological responses. Stressful events are
those which are threatening or, at the very least, unexpected and surprising, and the physiological and behavioral
responses are intended to promote adaptation via a process called “allostasis.” Chemical mediators of allostasis include
cortisol and adrenalin from the adrenal glands, other hormones, and neurotransmitters, the parasympathetic and sym-
pathetic nervous systems, and cytokines and chemokines from the immune system. Two brain structures, the amygdala
and hippocampus, play key roles in interpreting what is stressful and determining appropriate responses. The hip-
pocampus, a key structure for memories of events and contexts, expresses receptors that enable it to respond to gluco-
corticoid hormones in the blood. It undergoes atrophy in a number of psychiatric disorders; it also responds to stressors
with changes in excitability, decreased dendritic branching, and reduction in number of neurons in the dentate gyrus.
The amygdala, which is important for “emotional memories,” becomes hyperactive in posttraumatic stress disorder and
depressive illness. In animal models of stress, there is evidence for growth and hypertrophy of nerve cells in the amyg-
dala. Changes in the brain after acute and chronic stressors mirror the pattern seen in the metabolic, cardiovascular, and
immune systems, that is, short-term adaptation (allostasis) followed by long-term damage (allostatic load), eg, athero-
sclerosis, fat deposition obesity, bone demineralization, and impaired immune function. Allostatic load of this kind is seen
in major depressive illness and may also be expressed in other chronic anxiety and mood disorders.  
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(e-mail: mcewen@rockefeller.edu)amino acid neurotransmitters in the brain suppress neu-
rogenesis in dentate gyrus (DG) and causes debranching
of dendrites in hippocampus and medial prefrontal cor-
tex,whereas chronic stress causes neurons in amygdala
to show dendritic growth.
2-5The hippocampus contains
receptors for adrenal steroids,which regulate excitabil-
ity and morphological changes (Figure 1).Along with
many other brain regions, the amygdala also contains
adrenal steroid receptors,which influence function in this
structure as well (Table I).
Acute stress induces formation of spine synapses in CA1
region of hippocampus
6 and chronic stress also increases
spine synapse formation in hippocampus and amygdala.
7
The contrasting changes of dendrites in amygdala and
hippocampus after chronic restraint stress (CRS) offers
an unprecedented opportunity for understanding under-
lying mechanisms,as will be discussed below.
CRS for 21 days or longer impairs hippocampal-depen-
dent cognitive function
8,9 and enhances amygdala-depen-
dent unlearned fear and fear conditioning,
10 which are
consistent with the opposite effects of stress on hip-
pocampal and amygdala structure. CRS also increases
aggression between animals living in the same cage
(Table II).
11 Psychosocial stress suppresses neurogenesis
and causes dendritic shrinkage,
12-15 and one of these stress
models, the tree shrew, is considered to be a model of
human depressive illness.
16
Indeed,in major depression and a number of other mood
and anxiety disorders,there are reports of hippocampal
volume loss and enlargement of the amygdala.
17,18 Studies
in the tree shrew have shown that treatment with anti-
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Selected abbreviations and acronyms
CGRP calcitonin gene–related peptide
CRS chronic restraint stress
DG dentate gyrus
GR glucocorticoid receptor
IGF-1 insulin-like growth factor–1
MR mineralocorticoid receptor
NMDA N-methyl-D-aspartate
PSA-NCAM polysialated neural cell adhesion molecule
tPA  tissue plasminogen activator
Figure 1. The hippocampus is a target for adrenal steroids. GR, glucocorticoid receptor; MR, mineralocorticoid receptor; Sch, Schaffer colateral; MF,








MFdepressant,antiseizure,and mood-stabilizing drugs pre-
vents stress-induced hippocampal structural changes.
14,15,19
Besides reduced neurogenesis in DG,there is also evi-
dence for reduced size of principal neuron cell bodies in
hippocampus,which is consistent with reduced size of the
dendritic tree.
20 Synaptic reorganization is also a likely
consequence of these rather drastic structural changes,
and the animal models cited above provide evidence that
synapses can be rapidly formed as a result of stress.Taken
together, such structural changes seem likely to play a
major role in the volume loss in the human hippocampus
and the related effects on cognitive function and affect.
18
This article will review underlying mechanisms and con-
sider their applicability to furthering our understanding
of the pathophysiology of mood and anxiety disorders.
Allostasis and mechanisms for 
behavioral adaptation
The amygdala and hippocampus are both involved in con-
textual fear conditioning and in passive avoidance learn-
ing.In fear conditioning,glucocorticoids enhance learned
fear
21 and they play an important role in forming the mem-
ory of context in contextual fear conditioning,but not of
the actual effect of footshock in rats that are already famil-
iar with the context where the shock is administered.
22,23
This suggests that the hippocampal role in contextual fear
conditioning is enhanced by moderate levels of glucocor-
ticoids,but the fear conditioning is either not so dependent
on glucocorticoids or is so strong that glucocorticoid influ-
ences are hard to demonstrate.Yet there is evidence for an
influence of glucocorticoids on the flow of information
within the amygdala.
Glucocorticoids potentiate serotonin inhibition of the pro-
cessing of excitatory input to the lateral amygdala from the
thalamus, suggesting that there is a mechanism for con-
taining,or limiting,the sensory input that is important for
fear conditioning.
24Thus,adrenal steroids may regulate the
nature of the signals that reach the amygdala and allow for
greater discrimination of the most salient cues for learning.
Moreover,in passive avoidance,both catecholamines and
glucocorticoids play a role in facilitating learning.
25,26
Catecholamines work outside of the blood–brain barrier
and their effects can be blocked by β-adrenergic–blocking
agents, which do not cross the blood–brain barrier.
26
Glucocorticoids enter the brain, and local implants of
exogenous corticosterone into hippocampus,amygdala,
and nucleus tractus solitarii are all able to enhance passive
avoidance learning.
25
Adrenal steroids also play a supporting role in the learn-
ing of a spatial navigation task in mice.
27Adrenalectomy
impairs the acquisition of the memory of hidden platform
location in the Morris water maze, and glucocorticoid
administration restores the normal learning curve;how-
ever,in mice in which the glucocorticoid receptor (GR) is
deleted and replaced with a GR that lacks the DNA bind-
ing domain,glucocorticoids do not improve task acquisi-
tion.
27This finding illustrates a role for GRs acting upon
the genome in a task that is known to depend on the hip-
pocampus.Interestingly,other actions of glucocorticoids
via GRs are known to involve the protein–protein inter-
actions that are not prevented in mice carrying the GR
defective in the DNA binding domain.
28
Other evidence for glucocorticoid actions supports an
inverted U-shaped dose–response curve in which low to
moderate levels of adrenal steroids enhance acquisition of
tasks that involve the hippocampus,whereas high levels of
glucocorticoids disrupt task acquisition.
22,29-31 Adrenal
steroids have biphasic effects upon excitability of hip-
pocampal neurons, which may underlie their biphasic
actions on memory and recall.
30,32-34
Adaptive structural plasticity
One of the ways that stress hormones modulate function
within the brain is by changing the structure of neurons.
Within the hippocampus,the input from the entorhinal
cortex to the DG is ramified by the connections between
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Table I. Distribution of adrenal steroid receptors in brain regions. GR, glu-
cocorticoid receptor; MR, mineralocorticoid receptor.
Hippocampus MR and GR
Amygdala GR and some MR
Septum GR and some MR
Hypothalamus GR mostly; low levels of MR
Cerebral cortex GR mostly; low levels of MR
Midbrain GR mostly; low levels of MR
Brain stem GR mostly; patches of MR
Cerebellum GR mostly
Table II. Cumulative effects of restraint stress on behavior.
• Cognitive impairment, spatial recognition memory 
(hippocampus)
• Increased anxiety and enhanced fear conditioning 
(amygdala)
• Increased aggression (amygdala)the DG and the CA3 pyramidal neurons. One granule
neuron innervates,on average,12 CA3 neurons;and each
CA3 neuron innervates, on the average, 50 other CA3
neurons via axon collaterals,as well as 25 inhibitory cells
via other axon collaterals (Figure 2).
35The net result is a
600-fold amplification of excitation as well as a 300-fold
amplification of inhibition,which provide some degree
of control of the system.As to why this system exists,the
DG-CA3 system is believed to play a role in the memory
of sequences of events, although long-term storage of
memory occurs in other brain regions.
36,37
Neurogenesis in the DG
There is structural plasticity within the DG-CA3 system,
in that new neurons continue to be produced in the DG
throughout adult life
38 and CA3 pyramidal cells undergo
remodeling of their dendrites,
2 as will be discussed fur-
ther below.
39
The subgranular layer of the DG contains cells that have
properties of astrocytes (eg,expression of glial fibrillary
acidic protein) and give rise to granule neurons.
40After
administration of bromodeoxyuridine (BrdU) to label
DNA of dividing cells,these newly born cells appear as
clusters in the inner part of the granule cell layer,where
a substantial number of them will go on to differentiate
into granule neurons within as little as 7 days.The new
granule neurons appear to be quite excitable and capa-
ble of participating in long-term potentiation.In the adult
rat,9000 new neurons are born per day and survive with
a half-life of 28 days.
41
There are many hormonal and neurochemical modula-
tors of neurogenesis and cell survival in the DG.
15,38,42-44
Neurogenesis in the adult DG is enhanced by the hor-
mone insulin-like growth factor–1 (IGF-1) and by sero-
tonin and a number of antidepressant drugs. Estradiol
accelerates cell proliferation in female rats.IGF-1 is the
mediator of the ability of exercise to increase cell prolif-
eration in the DG.Lack of IGF-1 and insulin in diabetes
has the opposite effect and decreases cell proliferation.
Neurogenesis and/or survival of newly born cells is
increased by putting mice in a complex (“enriched”)
environment.
45 It is also increased by a form of classical
conditioning that activates the hippocampus (“trace con-
ditioning”) prolongs the survival of newly born DG neu-
rons.
46,47 On the other hand,certain types of acute stress
and many chronic stressors suppress neurogenesis or cell
survival in the DG,and the mediators of these inhibitor
effects include excitatory amino acids acting via 
N-methyl-D-aspartate (NMDA) receptors and endoge-
nous opioids.
2,48-50 Chronic stress has even more potent
effects on neurogenesis and neuronal survival.CRS for
21 days suppressed neurogenesis and CRS for 42 days
causes the number of DG neurons to decrease along with
total DG volume (Figure 3).
51
Remodeling of dendrites
Another form of structural plasticity is the remodeling of
dendrites in the hippocampus.
39 CRS causes retraction
and simplification of dendrites in the CA3 region of the
hippocampus (Figure 4).
2 Such dendritic reorganization
can also be seen in rats undergoing adaptation of psy-
chosocial stress in the visible burrow system (VBS).The
VBS is an apparatus with an open chamber where there
is a food and water supply and several tunnels and cham-
bers.
52 Rats can be observed from above by a video cam-
era in this apparatus.In the VBS,male rats housed with
several females establish a dominance hierarchy within
several days.Over the course of the next week,a few sub-
ordinate males may die and others (showing scars from
bite marks) will show enlarged adrenals, low testos-
terone,and many changes in brain chemistry.The domi-
nant shows the fewest scars and has the highest level of
testosterone,but also has somewhat larger adrenal glands
than cage control rats.
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Figure 2. Why is the CA3 so vulnerable? Feed-forward excitability serves
memory functions but increases vulnerability for excitotoxicity.
DG, dentate gyrus.Regarding changes in brain structure,it was the dominant
rats that had a more extensive pattern of debranching of
the apical dendrites of the CA3 pyramidal neurons in the
hippocampus,compared with the subordinate rats,which
showed reduced branching compared with the cage con-
trols.
53What this result emphasizes is that it is not adrenal
size or presumed amount of physiological stress per se that
determines dendritic remodeling, but a complex set of
other factors that modulate neuronal structure.We refer
to the phenomenon as “dendritic remodeling”and we gen-
erally find that it is a reversible process. In hibernating
hamsters,it occurs in a matter of hours and reverses itself
just as quickly when hibernating animals are aroused from
torpor (A.M.Magarinos,B.S.McEwen,P.Pevet,unpub-
lished data).Below we consider mechanisms involved in
structural remodeling.
The role of adrenal steroids in the structural remodeling
described above reflects may interactions with neuro-
chemical systems in the hippocampus,including serotonin,
γ-aminobutyric acid (GABA),and excitatory amino acids
(Figure 5).
2 Probably the most important interactions are
those with excitatory amino acids such as glutamate.
Excitatory amino acids released by the mossy fiber path-
way play a key role in the remodeling of the CA3 region
of the hippocampus,and regulation of glutamate release
by adrenal steroids may play an important role.
54-57 We
have found that the glutamate transporter,Glt-1,is ele-
vated by CRS in hippocampus, particularly in the CA3
region,providing another indication that elevated gluta-
mate levels are an important component of structural plas-
ticity.We previously showed that NMDA receptor block-
ade and the Na/Ca channel blocker,phenytoin,both block
CRS- and glucocorticoid-induced remodeling of dendrites
in CA3.
58-60 Recent evidence indicates that presynaptic
receptors containing kainate receptor subunits such as
GluR6 are important for the feed-forward actions of glu-
tamate on mossy fiber terminals,
61 and one study showed
that a number of kainate receptor subunit mRNAs are
regulated biphasically by adrenal steroids.
57 In particular,
preferential mineralocorticoid receptor (MR) occupancy
by low corticosterone (CORT) levels enhanced mRNA
levels for KAR2, GluR6, and GluR7.
57 This agrees with
our finding that MR activation by aldosterone in adrena-
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Figure 3. A single restraint stress does not suppress cell proliferation. Repeated restraint stress for 21 days suppresses cell proliferation. Repeated restraint
stress for 42 days reduces volume of the dentate gyrus (DG) and the number of neurons in the DG.
Reproduced from reference 51 with permission: Pham K, Nacher J, Hof PR, McEwen BS. Repeated restraint stress suppresses neurogenesis and induces biphasic
PSA-NCAM expression in the adult rat dentate gyrus. Eur J Neurosci. 2003;17:879-886. Copyright © 2003, Blackwell Publishing, Inc.
Figure 4. Hippocampal CA3 pyramidal neurons are remodeled by 21-d
restraint stress. A. Control. B. 21 days’ chronic restraint stress.
ABlectomized (ADX) rats restored levels of [
3H]kainate
binding in the mossy fiber region of CA3.
56 However,fur-
ther studies are needed.
Because excitatory amino acids play a key role along with
circulating glucocorticoids, the activation of the CREB
(cyclic adenosine monophosphate response element–bind-
ing protein) system is a likely candidate mediator, and
recent evidence indicates that phosphorylation of CREB
is chronically activated in rats subjected to CRS.CREB
has been linked to regulation of synaptic plasticity and par-
ticularly neurogenesis.
62 It is possible that CREB is
involved in activity-dependent synapse formation,which
is evident as a result of long-term potentiation.
63,64
However,the role of glucocorticoids in activation of the
CREB system has not been thoroughly investigated.
Nevertheless,treatment with the mood stabilizer lithium
prevented CRS-induced structural remodeling of the
stress-induced elevation of Glt-1 and CREB phosphory-
lation (G. E.Wood, L.T.Young, B. S. McEwen, unpub-
lished data),providing further evidence that CRS-induced
structural plasticity and the molecular markers Glt-1 and
phosphoCREB are useful in study of psychiatric illnesses.
Structural changes in dendrites and spine synapses are
the result of modifications in the microtubule system of
the cytoskeleton,
65 and new evidence shows that post-
translational modification of tubulin
65 and phosphoryla-
tion of the microtubule associated protein tau
66 take
place along with changes in the actin cytoskeleton,
67
under conditions in which reorganization of dendrites
and synaptic connections occur. Overall, cytoskeletal
changes,such as increased paired-helical-like phospho-
rylation of tau
66 and reduced tyrosinated tubulin,
65 are
consistent with increased cytoskeletal rigidity.However,
this needs much careful study.
The Rac/Rho guanosine triphosphatases (GTPases) and
related proteins such as the guanosine triphosphate
(GTP) exchange factor,kalirin,have been shown to play
a key regulatory role in cytoskeletal modifications in
developing and adult neurons.
67,68 Except for one relevant
study on seizures,
65 there are no studies thus far of the
effects of chronic stress on these pathways or of the mod-
ifications of the cytoskeleton itself.
Besides glucocorticoids and excitatory amino acids,neu-
rotrophins and gp130 cytokines are implicated in struc-
tural plasticity along with extracellular proteases such as
tissue plasminogen activator (tPA) and neuropsin.Brain-
derived neurotrophic factor (BDNF) plays a major role
in activity-dependent synaptic and dendritic remodel-
ing,
69-73 and is implicated in hippocampal-dependent
memory formation.
74 BDNF also regulates tPA release
from neurons
75 and tPA is released from nerve terminals
in hippocampus and other brain areas such as amyg-
dala.
76-78 It has been suggested that tPA may play a role in
the processing of proBDNF into active forms.
79The activ-
ity of tPA is associated with structural plasticity and
increased fear,
77 motor learning,
80 and enhancement of
long-term potentiation.
81Activity of tPA is an important
mediator of structural plasticity and enhanced fear in the
amygdala resulting from acute restraint stress.For exam-
ple, plasminogen (inactive zymogen) leads to plasmin
(active serine protease).Using tPA knockout mice,we
have found that in medial and central amygdala
77:
• tPA is released under stress and initiates neural remod-
eling.
•This release is plasminogen-independent (extracellular
signal–regulated kinase [ERK1/2];guanosine triphos-
phate–activating protein [GAP-43]).
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Figure 5. Glucocorticoids increase glutamate levels, N-methyl-D-aspartate
(NMDA) receptors, calcium currents, 5-hydroxytryptamine (5-HT)
turnover, and 5-HT2 receptors, decrease 5-HT1A receptors, and
alter subunit expression of GABAA receptors. A. Cross-section
of dorsal hippocampus. B. Blow-up of CA3 region. C. CA3 neu-
rons highlighting stratum lucium (SL), where mossy fiber termi-
nals form synaptic contacts .GABA, γ-aminobutyric acid; DG,
dentate gyrus; SR, stratum radiatum; SP, stratum pyramidale;
SO, stratum oriens.
• Glutamate levels ++
• NMDA receptors ++
• Ca++ currents ++
• 5-HT turnover ++
• 5-HT2 receptors ++
• 5-HT1A receptors  --
• GABAA receptors +/-Structural plasticity of the adult brain - McEwen Dialogues in Clinical Neuroscience - Vol 6 . No.2 . 2004
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• tPA induces termination of its own action via plas-
minogen-activator inhibitor–1 (PAI-1).
• tPA activity is required for increased anxiety in the ele-
vated plus maze.
We are presently studying the long-term effects of stress.
Neuropsin is another protease that is induced in hip-
pocampus by NMDA-mediated excitation in seizures
and leads to proteolysis of the presynaptic adhesion mol-
ecule,L1.
82
The gp130 cytokines are expressed in hippocampus
under stimulation by seizures,along with their receptors,
which are constitutively expressed.
83 Leukemia inhibitory
factor (LIF) is particularly interesting because it inter-
feres with neurotrophin signaling
84 and causes dendritic
retraction in cell culture.
85 However,it has not yet been
determined whether acute or chronic stress increases LIF
expression,and it is conceivable that increased expres-
sion of LIF might play a role in dendritic shortening.
The ability of neuronal processes to expand or contract,
and newly formed neurons to make connections,is depen-
dent on the extracellular environment in which poly-
sialated neural cell adhesion molecule (PSA-NCAM)
plays an important role.
86 PSA-NCAM is associated with
regions of the brain that show structural plasticity such as
the inner granule cell layer of the DG and the mossy fiber
terminals of CA3.
87 CRS for 21 days causes increased
PSA-NCAM expression in the DG proliferative zone even
though cell proliferation is suppressed,and these changes
have disappeared after CRS for 42 days.
51This raised ques-
tions about the role of PSA-NCAM in adaptive structural
plasticity,which need to be investigated.Removal of the
PSA residue by endoneuraminidase (EndoN)
88 is a pow-
erful tool for manipulating this system,since PSA removal
abolishes plasticity of suprachiasmatic neurons to envi-
ronmentally induced phase shifting of the diurnal rhythm.
89
We now turn to the important question of whether chronic
stress increases or decreases vulnerability of the hip-
pocampus to damage from other insults.
Permanent damage as a result of stress
The remodeling of the hippocampus in response to stress
is largely reversible if the CRS is terminated at the end of
3 weeks.
10After 3 weeks of CRS,neurogenesis is reduced
in DG and dendrites are shorter and less branched,
51,59,60
and there is an increase in PSA-NCAM expression in the
DG that is consistent with increased mobility of neuronal
processes even in the face of reduced DG neuron pro-
duction.Continuation of CRS for a total of 6 weeks abol-
ishes the upregulation of PSA-NCAM and results in a sig-
nificant 6% reduction in DG volume and 13% reduction
in granule neuron number.
51We do not yet know whether
structural changes occurring after 6 weeks of CRS are
reversible or whether they can be accelerated by antide-
pressant or antiepileptic drugs that block the effects of
stress and glucocorticoids on remodeling.Nor do we know
whether the structural changes occurring with CRS
increase or decrease the vulnerability of the hippocampus
to damage by excitotoxicity.
It is well established that glucocorticoids exacerbate
damage to the hippocampus caused by ischemia
90 and
seizures.
91,92 Glucocorticoids exacerbate excitotoxic dam-
age and do so,at least in part,by facilitating trafficking
of immune cells to the injury site,
93 and,there,cytotoxic
T cells are able to produce cytotoxic death of neurons.
94
However,the phenomenon of ischemic preconditioning
95
reveals that prior stimulation of the hippocampus can
induce a protective mechanism that may reduce the dam-
age produced by a full-scale ischemic event.It is not clear
whether the same mechanisms might be operative when
stress is applied and whether they might affect the
response to excitotoxicity in response to seizures,but this
possibility needs to be kept in mind if it turns out that prior
CRS has a protective effect on subsequent responses to
excitotoxic challenge.
Protective agents may also involve substances that are
upregulated in the brain in response to damage or threat
of damage.One of the prominent features of excitotoxic
damage or removal of adrenal steroids is the robust induc-
tion of calcitonin gene–related peptide (CGRP) in termi-
nals and cell bodies in hippocampus and in mossy cells.
The increased expression of CGRP in mossy cells is espe-
cially prominent after bilateral ADX under conditions in
which there is apoptosis of granule cells,and the CGRP
immunoreactivity is enhanced within the inner third of the
molecular layer of the DG.The neuroimmune peptide,
CGRP, is one of the most diverse and influential
immunoregulators of the periphery.This important neu-
ropeptide has multiple functions including:its actions as a
potent vasodilator
96 and an immune modulator,
97-102 as well
as a neural and immune developmental regulator,a mod-
ulator of hormone release involved in growth and devel-
opment,and a stimulator of sympathetic outflow,which is
mediated by CRF and an inducer of apoptosis (reviewed
in reference 103).Some of the different functional roles
for CGRP may not be independent,but may be part of acascade of events that constitute the healing response to
injury. A number of studies have shown that CGRP is
expressed following various kinds of trauma and plays an
important role in the acute phase response that may be of
particular relevance to the outcome of the regional injury
response in the central nervous system (CNS).
103,104
In recent studies,the expression of CGRP within the hip-
pocampus increases in four separate models of CNS
injury:ADX,
105 intrahippocampal colchicine injection,
105
trimethyltin ingestion,
106 and kainic acid injections. In
each case,the expression of this peptide was limited to
the specific region of damage and in association with the
surviving neuronal population.Although the upregula-
tion of CGRP may be associated with neuronal cell sur-
vival,
107 other studies have shown that both microglia and
astrocytes express CGRP receptors and that exposure to
physiological levels of CGRP induces c-fos in microglia
and astrocytes and increases plasminogen activators.
108
The role of CGRP may then not only protect against
immune system damage to neurons,but may also partic-
ipate in plasticity and healing.
Protective and damaging effects 
of the mediators of adaptation
Individual differences in the progression of a number of
disorders that accumulate with time can be conceptual-
ized as an accumulation of wear and tear of daily expe-
riences,lifestyle,and major life stressors,which interact
with the genetic constitution and predisposing early life
experiences.
109-111The neuroendocrine system,autonomic
nervous system, and immune system are mediators of
adaptation to the challenges of daily life,referred to as
“allostasis,” meaning “maintaining stability through
change.”
112 Physiological mediators, such as adrenalin
from the adrenal medulla, glucocorticoids from the
adrenal cortex,and cytokines from cells of the immune
system,act upon receptors in various tissues and organs
to produce effects that are adaptive in the short term,but
can be damaging if the mediators are not shut off when
no longer needed.When release of the mediators is not
efficiently terminated,their effects on target cells are pro-
longed,leading to other consequences that may include
receptor desensitization and tissue damage.This process
has been named “allostatic load,”
113,114 which refers to the
price the tissue or organ pays for an overactive or ineffi-
ciently managed allostatic response.Therefore,allostatic
load refers to the “cost”of adaptation.
The brain is the master controller of the three systems
noted above and is also a target of these systems,subject
to both protection and damage.Allostasis also applies
not only to circulating hormones,but also to organs and
tissues of the body.In the nervous system,neurotrans-
mitters are released by neuronal activity,and they pro-
duce effects locally to either propagate or inhibit further
neural activity.Neurotransmitters and hormones are usu-
ally released during a discrete period of activation and
then are shut off, and the mediators themselves are
removed from the intracellular space by reuptake or
metabolism in order not to prolong their effects.When
that does not happen, however, there is allostatic load
and the brain is at increased risk for damage.
115,116
The processes of allostasis and allostatic load have been
described and measured for metabolic and cardiovascular
changes that are associated with obesity,type 2 diabetes,
and cardiovascular disease.
117 However,the same type of
elevated and prolonged secretion of glucocorticoids dur-
ing aging has also been associated with impairment of cog-
nitive function in rodents
118-120 and humans.
121-123 Moreover,
the endogenous excitatory amino acid neurotransmitters
appear to play a major role in these changes,
119 even
though they are also an essential part of normal synaptic
neurotransmission and plasticity.
Allostatic states in depressive illness
Stress hormones are elevated in major depressive illness.
In particular the diurnal rhythm is distorted.
124 Normally
low evening levels of cortisol are increased in a subset of
depressed patients
125,126 and the stress hormone axis in
major depression is resistant to suppression by the syn-
thetic glucocorticoid dexamethasone.
127 It is also notewor-
thy that androgen levels are elevated in women with major
depression,which undoubtedly reflects adrenal hyperac-
tivity.
128 IGF-1 levels are also reported to be elevated in
major depression, and this may reflect elevated growth
hormone release as a result of the hypercortisolemia.
129
Each of these patterns of elevation constitutes an “allo-
static state,”and represents a pathway for the development
of allostatic load in the brain and in other organs through-
out the body.Regarding the brain,we already noted the
studies showing that hippocampal volume loss in major
depressive illness is related to duration of the depression
rather than to age per se of the patients.
130-132 Not all stud-
ies report such changes (see,for example,references 133
and 134);the reasons for these different results are beyond
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126the scope of this discussion,but they may be explained by
differences in the duration of depression,as well as gender
and age. It should be noted that hippocampal size in
elderly twins shows only 40% genetic contribution,with
the predominant influence being environmental.
135 This
emphasizes the importance of experimental factors and
allostatic load in determining hippocampal volume.
Hippocampal atrophy has been found in relation to
depression in the elderly,
136 with an association detected
with presence of the ApoE4 genotype.
137 In subjects with
a long-term history of depression,Sheline and colleagues
described magnetic resonance imaging (MRI) evidence
for discontinuities that might represent sites of damage.
130
Although some recent postmortem studies on brains from
depressed individuals did not show neuron loss in hip-
pocampus,
138,139 the duration of the depression and the sub-
type of depression were not carefully controlled.Thus,the
possibility that neural damage may ultimately occur in
major depression cannot be disregarded,particularly when
depression lasts a long time.However,in a recent study in
young depressed subjects,hippocampal volume was not
smaller in first-episode depression,but declined rapidly
over several years.
140 The key, unanswered question is
whether such changes can be prevented or even reversed.
It is important to note that other brain regions besides
hippocampus are affected in depressive illness and
undergo structural changes.One region is the prefrontal
cortex,and structural imaging
141 showed loss of volume
in familial pure depressive disorder, whereas autopsy
studies
142-144 have shown loss of volume and glial cells,as
well as neuronal density in both unipolar and bipolar dis-
order.There is one animal study showing that chronic
glucocorticoid treatment induces loss of dendrites in the
rat prefrontal cortex.
4 However,much more work needs
to be done on this brain region.
Depressive illness is associated with a hyperactivation of
the amygdala,
145,146 and more recently, with an actual
enlargement of the amygdala in the first episode of major
depression.
147This is reminiscent of the increased dendritic
branching reported in rats after repeated immoblization
stress (see above and reference 148).Since the amygdala
integrates information related to fear and strong emotions,
and also sends outputs via the central nucleus for auto-
nomic arousal and via the basal nucleus for more active
aspects of coping,
149 the elevation of amygdala activity may
be a first step that leads to overactivation of systems
involved in physiological and behavioral coping.
The long-term consequences of this may well be a wear
and tear on the body that results in a number of patho-
physiological consequences,since the amygdala regulates
both autonomic nervous system activity and adrenocor-
ticotropic hormone (ACTH) and cortisol production
through outputs of its central nucleus.
149,150 It is important
to note that there are reports that in recurrent major
depression of long duration the amygdala may undergo
shrinkage.
131,151 It is thus possible that initial hypertrophy
gives way to atrophy in this important brain structure.
Besides the brain changes in major depression,there are
other changes in the body that reflect dysregulated hypo-
thalamopituitary axis (HPA) and autonomic activity,and
are slow in developing.These constitute allostatic load that
produces cumulative pathophysiology,which may also be
reversible if caught in time.Such cumulative,long-term
effects include bone mineral loss
152-154 and abdominal fat
deposition.
155-157 Moreover,the combination of long-term
allostatic load, together with dysregulation of the auto-
nomic nervous system in major depression,
158 is associated
with increased blood platelet reactivity
159-161 and increased
risk for cardiovascular disease.
162-165
There are parallels between the story for major depression
and what is known about psychiatric and somatic features
of Cushing’s disease involving melancholia,depression,
abdominal obesity,bone mineral loss,and increased risk
for cardiovascular disease.
166-169 In addition, there is evi-
dence for hippocampal atrophy in Cushing’s disease along
with memory impairments.
170-172 Interestingly,hippocampal
volume loss in Cushing’s disease is at least partially
reversible over several years after correction of the hyper-
cortisolemia.
173-175
Finally,a largely unexplored area concerns the effects of
antidepressant medication on the brain and body
changes associated with depressive illness. On the one
hand,certain antidepressants may contribute to some of
the associated pathophysiology,such as cardiovascular
instability.
176 On the other hand,withdrawal from antid-
pressant treatment may cause imbalances in neurotrans-
mitter systems,with elevations of excitatory amino acid
tone,
177 and contribute to the allostatic load that occurs
as the depressive state continues.
178
Conclusion
Translational studies of brain changes in major psychiatric
illnesses such as unipolar and bipolar depression and post-
traumatic stress disorder are showing that changes in vol-
ume of structures such as hippocampus,prefrontal cortex,
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Plasticidad estructural del cerebro adulto: cómo los modelos animales nos ayudan a 
comprender los cambios cerebrales en la depresión y los trastornos sistémicos relacionados
con la depresión
El cerebro interpreta experiencias y las traduce en respuestas conductuales y fisiológicas. Los aconteci-
mientos estresantes son aquellas situaciones amenazantes, o al menos, inesperadas y sorpresivas; y las res-
puestas fisiológicas y conductuales intentan promover una adaptación a través de un proceso llamado
“alostasis.” Los mediadores químicos de la alostasis incluyen el cortisol y la adrenalina de las glándulas
adrenales, otras hormonas y neurotransmisores, el sistema nervioso parasimpático y simpático, y citoqui-
nas y quimioquinas del sistema inmune. Dos estructuras cerebrales, la amígdala y el hipocampo, juegan
papeles clave en la interpretación de lo que es estresante y en la determinación de respuestas apropiadas.
El hipocampo, una estructura clave para las memorias de los acontecimientos y del contexto, expresa recep-
tores que lo capacitan para responder a hormonas glucocorticoídeas de la sangre. El hipocampo se atro-
fia en numerosos trastornos psiquiátricos y también responde a estresores con cambios en la excitabilidad,
disminución de las ramificaciones dendríticas y reducción del número de neuronas del giro dentado. La
amígdala, que es importante para las “memorias emocionales,” aumenta su actividad en el trastorno por
estrés postraumático y en la enfermedad depresiva. En modelos animales de estrés existen evidencias del
crecimiento e hipertrofia de células nerviosas en la amígdala. Los cambios en el cerebro después de situa-
ciones de estrés agudo y crónico reflejan el patrón observado en los sistemas metabólico, cardiovascular e
inmune; esto es, una adaptación a corto plazo (alostasis) seguida de un daño a largo plazo (carga alostá-
tica), como por ejemplo, ateroesclerosis, obesidad localizada, desmineralización del hueso y deterioro de
la función inmune. La carga alostática de este tipo se observa en la depresión mayor y también se puede
expresar en otros trastornos ansiosos y afectivos crónicos.
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Plasticité structurale du cerveau adulte : comment les modèles animaux nous aident à 
comprendre les modifications cérébrales dans la dépression et les troubles généraux liés 
à la dépression
Le cerveau interprète les expériences et les traduit en réponses comportementales et physiologiques. Les
événements stressants sont ceux qui sont menaçants ou tout au moins inattendus et surprenants et les
réponses physiologiques et comportementales ont pour but de promouvoir l’adaptation via un proces-
sus appelé « allostasie ». Les médiateurs chimiques de l’allostasie incluent le cortisol et l’adrénaline sécré-
tés par les glandes surrénales, d’autres hormones et des neurotransmetteurs, les systèmes nerveux sym-
pathique et parasympathique, et les cytokines et chimiokines produites par le système immunitaire. Deux
structures cérébrales, l’amygdale et l’hippocampe, jouent un rôle-clé dans l’identification des événements
stressants et l’élaboration de réponses appropriées. L’hippocampe, une structure-clé pour les souvenirs des
événements et contextes, exprime des récepteurs qui lui permettent de répondre aux hormones gluco-
corticoïdes du sang. Il subit une atrophie au cours de nombreux troubles psychiatriques et réagit égale-
ment aux facteurs de stress par des changements de l’excitabilité, une diminution de la ramification den-
dritique et une baisse du nombre de neurones dans le gyrus denté. L’amygdale, qui joue en rôle important
dans les « souvenirs émotionnels », devient hyperactive dans l’état de stress posttraumatique et la dépres-
sion. Les modèles animaux de stress montrent l’existence d’une croissance et d’une hypertrophie des cellu-
les nerveuses dans l’amygdale. La chronologie des modifications du cerveau à la suite de stress aigus ou
chroniques (adaptation à court terme [allostasie] suivie d’une altération à long terme [charge allostati-
que]), reflète celle observée au cours des affections touchant, par ex., les systèmes métabolique, cardio-
vasculaire et immunitaire, où la phase d’adaptation se complique, respectivement, d’athérosclérose et obé-
sité localisée, de déminéralisation osseuse et d’altérations de la fonction immunitaire. Une telle charge
allostatique se rencontre dans la dépression majeure et peut aussi s’exprimer dans l’anxiété chronique et
d’autres troubles de l’humeur.74. Alonso M, Vianna MRM, Depino AM, et al. BDNF-triggered events in the
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